Restart Life Sciences Corp logo

Restart Life Sciences Corp

XCNQ:HEAL (Canada)  
C$ 0.04 (+16.67%) Nov 27
At Loss
Market Cap:
C$ 1.26M ($ 900.00K)
Enterprise V:
C$ 1.31M ($ 933.00K)
Volume:
15.00K
Avg Vol (2M):
20.39K
Trade In:
Volume:
15.00K
At Loss

Business Description

Description
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.2
Equity-to-Asset -40.23
Debt-to-Equity -0.06
Debt-to-EBITDA -0.14
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3343.73
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.79
9-Day RSI 52.05
14-Day RSI 52.35
6-1 Month Momentum % -66.67
12-1 Month Momentum % -80

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01
Cash Ratio 0.01
Days Sales Outstanding 78.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -65.3

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -1528.57
Net Margin % -1496.43
FCF Margin % -175
ROA % -1047.5
ROIC % -839.22
ROC (Joel Greenblatt) % -3890.91

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 35
EV-to-EBIT -3.06
EV-to-EBITDA -3.08
EV-to-Revenue 46.75
EV-to-FCF -26.71
Earnings Yield (Greenblatt) % -32.68
FCF Yield % -3.89

Financials

XCNQ:HEAL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Restart Life Sciences Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.028
EPS (TTM) (C$) -0.014
Beta -2
Volatility % 81.56
14-Day RSI 52.35
14-Day ATR (C$) 0.003992
20-Day SMA (C$) 0.0325
12-1 Month Momentum % -80
52-Week Range (C$) 0.015 - 0.125
Shares Outstanding (Mil) 36.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Restart Life Sciences Corp Filings

Filing Date Document Date Form
No Filing Data

Restart Life Sciences Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Restart Life Sciences Corp Frequently Asked Questions

What is Restart Life Sciences Corp(XCNQ:HEAL)'s stock price today?
The current price of XCNQ:HEAL is C$0.04. The 52 week high of XCNQ:HEAL is C$0.13 and 52 week low is C$0.02.
When is next earnings date of Restart Life Sciences Corp(XCNQ:HEAL)?
The next earnings date of Restart Life Sciences Corp(XCNQ:HEAL) is .
Does Restart Life Sciences Corp(XCNQ:HEAL) pay dividends? If so, how much?
Restart Life Sciences Corp(XCNQ:HEAL) does not pay dividend.

Press Release

Subject Date
No Press Release